Find out more about contract manufacturing giant Integer — including its $131 million Aran Biomedical acquisition — at MD&M West this week in Anaheim, California.
Integer is exhibiting at Booth No. 2615 at the show, which runs through April 14.
“We are truly stronger together with the addition of Oscor and Aran Biomedical to the Integer team,” said Payman Khales, president of Integer’s Cardio & Vascular business. “Our expanded capabilities not only meet our customers’ evolving needs, but additionally enable them to get to market faster. We look forward to showcasing this and more at MD&M West.”
Integer is showcasing examples of how it can expedite time to market. They include designing and developing full lead systems and sub-assemblies, vertically integrated manufacturing, and customizable services to complement customers’ existing capabilities.
Integer also has its new Xcellion Gen 3 lithium-ion fast charge rechargeable batteries. The company says the batteries reduce charging time by up to 70%, increase battery runtime by up to 30% and retain 70% original capacity after 6,000-plus full cycles.
The company’s MD&M West booth includes examples of finished guiding sheaths ready for OEM branding:
- The Destino Reach line has a wide range of deflectable sheaths specific to electrophysiology (EP)/transseptal procedures in various French sizes and lengths.
- The Destino Twist HTS is a peripheral and intracardiac sheath with a short handle deflectable guiding sheath. Integer says it eliminates the need for brachial access and provides a stable platform for delivery catheters, guidewires and stents.
